Industry Wire 214

September 27, 2024 Jake Fishman 0 min read
  1. LAPD officer’s gun sucked into MRI machine during raid.
  2. Dems introduce legislation to permanently lower ACA plan costs. 
  3. Cardinal Health acquires Integrated Oncology Network for $1B.
  4. CDC: 40.3% of U.S adults are obese, 46.5% of adults aged 40-59.
  5. VA’s new Oracle EHR saw 826 ‘major’ incidents since its launch.
  6. U.S. House committee passes rare pediatric disease drug bill.
  7. 29% of Americans have undiagnosed iron deficiency.
  8. Senate holds Steward Health CEO in criminal contempt.
  9. PA-based system fires workers for sharing inappropriate patient images.
  10. Providers say reimbursement denials are getting worse.
Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like

Cardiology Pharmaceuticals February 2, 2026

CKM’s True Medication Burden February 2, 2026

As cardiology begins to look at the spectrum of cardiovascular-kidney-metabolic disease, new research in JAMA suggests that CKM treatments might face serious adoption challenges due to the sheer number of Americans who both have the disease and qualify for medications. In a search for just how many eligible patients are out there, researchers examined FDA-approved […]

Heart Failure January 29, 2026

Telemedicine’s Unintended HF Consequences January 29, 2026

Heart failure telemedicine doesn’t seem to be lining up evidence-based care after a recent Stanford Medicine analysis revealed that remotely-managed HF patients received less diagnostic testing and saw serious dips in guideline-directed medical therapy. With the rising popularity of remote patient management in cardiology, Stanford researchers decided to explore telemedicine’s HF impact by tracking 44 […]

Cardiology Policy January 26, 2026

Women Need Lower LV Thresholds for AV Surgery January 26, 2026

New multicenter data published in JAMA suggests that surgery for aortic regurgitation may need to be done earlier than current guidelines recommend, with lower LV size thresholds and possibly different cutoffs for men and women. Studying several cohorts, researchers followed 808 patients with symptomatic AR and preserved LVEF with a median 7-year follow-up examining mortality […]